This CME activity is supported by an educational grant from GlaxoSmithKline, Research
Triangle Park, North Carolina.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi.Brit Heart J. 1976; 38: 659-664
- Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.N Engl J Med. 1980; 303: 897-902
- The pathogenesis of coronary artery disease and the acute coronary syndromes.N Engl J Med. 1992; 326 (;310–318): 242-250
- Plasma-fibrinogen and thromboemboli after myocardial infarction.Lancet. 1976; 2: 1161-1164
- Community study of the causes of “natural” sudden death.BMJ. 1988; 297: 1453-1456
- Low-molecular-weight heparin during instability in coronary artery disease.Lancet. 1996; 347: 561-568
- Comparison of fondaparinux and enoxaparin in acute coronary syndromes.N Engl J Med. 2006; 354: 1464-1476
- Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.JAMA. 2006; 295: 1519-1530
- A meta-analysis of 4 randomized double blind studies.Arch Intern Med. 2003; 62: 1833-1840
- Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.Ann Intern Med. 2004; 140: 867-873
- Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.N Engl J Med. 2003; 349 (; erratum, N Engl J Med 2004;350:423): 1695-1702
- Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction.JAMA. 2006; 295: 1519-1530
- Bivalirudin for patients with acute coronary syndromes.N Engl J Med. 2006; 355: 2203-2216
- Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.N Engl J Med. 2006; 354: 1477-1488
- Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial.Circulation. 1997; 95: 2015-2021
- Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative.J Thromb Thrombolysis. 2006; 21: 211-220
- Heart disease and stroke statistics—2007 update.Circulation. 2007; 115: e69-e171
Article Info
Publication History
Accepted:
May 10,
2007
Received:
May 10,
2007
Footnotes
This manuscript is based upon a meeting of the authors that took place on November 21, 2006.
Identification
Copyright
© 2007 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
